Showing results (421-430 of 495) with videos related to

Sort By:
Pageof 50
European Journal of Pharmacology|April 9, 2002
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptorsJason W Brooks, Gareth Pryce, Tiziana Bisogno, et al.
European Journal of Epidemiology|July 4, 2024
Survival outcomes and healthcare utilization between immigrant patients and Danish-born patients with hematological cancers: a Danish population-based studyJoachim Baech, Lasse Hjort Jakobsen, Mikkel Runason Simonsen, et al.
BMJ Open|February 10, 2024
A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care (nursing home) (ADEPT): protocol for a feasibility studyMonique S Boord, Peter Brown, Julian Soriano, et al.
Brain : a Journal of Neurology|July 15, 2021
Balance between competing spectral states in subthalamic nucleus is linked to motor impairment in Parkinson's diseaseSaed Khawaldeh, Gerd Tinkhauser, Flavie Torrecillos, et al.
Elife|July 26, 2017
Subthalamic nucleus gamma activity increases not only during movement but also during movement inhibitionPetra Fischer, Alek Pogosyan, Damian M Herz, et al.
Nature Reviews. Neurology|January 27, 2019
Deep brain stimulation: current challenges and future directionsAndres M Lozano, Nir Lipsman, Hagai Bergman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2008
High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performanceAndrea A Kühn, Florian Kempf, Christof Brücke, et al.
Annals of Clinical and Translational Neurology|August 13, 2019
Predicting motor, cognitive & functional impairment in Parkinson'sChristine Lo, Siddharth Arora, Fahd Baig, et al.
Brain : a Journal of Neurology|December 24, 2016
Stimulating at the right time: phase-specific deep brain stimulationHayriye Cagnan, David Pedrosa, Simon Little, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2018
Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-UpSandra Lockmer, Bjørn Østenstad, Hans Hagberg, et al.
Pageof 50